Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Lung Cancer (Amsterdam, Netherlands)|January 1, 2021
Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitorsB Abbar, V De Castelbajac, P Gougis, et al.
Revue Des Maladies Respiratoires|February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]J Tredaniel, F Mornex, I Barillot, et al.
Revue Des Maladies Respiratoires|February 22, 2008
[How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study]D Moro-Sibilot, F Barlesi, J F Timsit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2014
A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancerS Novello, B Besse, E Felip, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancerE Quoix, B Lebeau, A Depierre, et al.
Respiratory Medicine and Research|June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemicN Girard, L Greillier, G Zalcman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancerL Derosa, M D Hellmann, M Spaziano, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2022
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancerJ Trédaniel, F Barlési, C Le Péchoux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2022
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743S Peters, A Scherpereel, R Cornelissen, et al.
Cancer Research|December 15, 1993
Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surfaceR Lubin, B Schlichtholz, D Bengoufa, et al.
Pageof 12